SLC16A1 and breast carcinoma: For instance, MCT1 (SLC16A1), a predicted direct target of miR-342-3p (Table S3), acts as a monocarboxylate transporter which serves as the main lactate transporter in breast cancer cells and its over-expression has been associated with poor clinical outcomes18–20.